Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

NCT00549510 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: COREG CR and lisinopril (FDC)

Sponsor

GlaxoSmithKline